Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2012, Article ID 378467, 5 pages
http://dx.doi.org/10.1155/2012/378467
Case Report

Pulmonary Hypertension in Pulmonary Langerhans Cell Granulomatosis

1Medical Mission Hospital and Department of Internal Medicine, Academic Teaching Hospital, University of Würzburg, Salvatorstrasse 7, 97064 Würzburg, Germany
2Institute of Pathology, Heidelberg University, Im Neuenheimer Feld 220, 69120 Heidelberg, Germany

Received 5 December 2011; Revised 16 December 2011; Accepted 16 December 2011

Academic Editor: Stephen P. Peters

Copyright © 2012 Matthias Held et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Delobbe, A. Duhamel, and B. Wallaert, “Group d etude en pathologie interstitielle de la société et pathologie thoracique du nord,” European Respiratory Journal, vol. 9, no. 10, pp. 2002–2006, 1996. View at Google Scholar
  2. A. Tazi, “Adult pulmonary Langerhans' cell histiocytosis,” European Respiratory Journal, vol. 27, no. 6, pp. 1272–1285, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. G. Dauriat, H. Mal, G. Thabut et al., “Lung transplantation for pulmonary Langerhans' cell histiocytosis: a multicenter analysis,” Transplantation, vol. 81, no. 5, pp. 746–751, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. R. S. Crausman, C. A. Jennings, R. Tuder, L. M. Ackerson, C. G. Irvin, and T. E. King Jr., “Pulmonary histiocytosis X: pulmonary function and exercise pathophysiology,” American Journal of Respiratory and Critical Care Medicine, vol. 153, no. 1, pp. 426–435, 1996. View at Google Scholar · View at Scopus
  5. B. A. Keogh, E. Lakatos, D. Price, and R. G. Crystal, “Importance of the lower respiratory tract in oxygen transfer, exercise testing in patients with interstitial and destructive lung disease,” American Review of Respiratory Disease, vol. 129, supplement 2, pp. S76–S80, 1984. View at Google Scholar
  6. H. M. Fartouk, M. Humbert, F. Capron et al., “Simonneau G severe pulmoanary hypertension in histiocytosis X,” American Journal of Respiratory and Critical Care Medicine, vol. 161, pp. 216–223, 2000. View at Google Scholar
  7. S. Harari, G. Simonneau, E. de Juli et al., “Medical management of heart failure and candidate selection, prognostic value of pulmonary hypertension in patients with chronic interstitial lung disease referred for lung or heart-lung transplantation,” Journal of Heart and Lung Transplantation, vol. 16, no. 4, pp. 460–446, 1997. View at Google Scholar
  8. D. N. Sauder, C. A. Dinarello, and V. B. Morhenn, “Langerhans cell production of interleukin-1,” Journal of Investigative Dermatology, vol. 82, no. 6, pp. 605–607, 1984. View at Google Scholar · View at Scopus
  9. S. Asakura, T. V. Colby, and A. H. Limper, “Tissue localization of transforming growth factor-β1 in pulmonary eosinophilic granuloma,” American Journal of Respiratory and Critical Care Medicine, vol. 154, no. 5, pp. 1525–1530, 1996. View at Google Scholar · View at Scopus
  10. L. Kiakouama, V. Cottin, B. Etienne-Mastroïanni, C. Khouatra, M. Humbert, and J. F. Cordier, “Severe pulmonary hypertension in histiocytosis X: long-term improvement with bosentan,” European Respiratory Journal, vol. 36, no. 1, pp. 202–211, 2010. View at Google Scholar